CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 143 filers reported holding CABALETTA BIO INC in Q2 2024. The put-call ratio across all filers is 2.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,188,000 | -47.8% | 2,064,263 | 0.0% | 0.54% | -40.9% |
| Q1 2022 | $4,190,000 | -46.4% | 2,064,263 | 0.0% | 0.92% | -37.7% |
| Q4 2021 | $7,824,000 | -72.7% | 2,064,263 | -12.5% | 1.47% | -74.8% |
| Q3 2021 | $28,689,000 | +11.8% | 2,359,263 | -20.9% | 5.82% | -9.8% |
| Q2 2021 | $25,665,000 | -22.5% | 2,984,263 | 0.0% | 6.46% | +8.3% |
| Q1 2021 | $33,125,000 | -21.3% | 2,984,263 | -11.5% | 5.96% | -57.9% |
| Q4 2020 | $42,073,000 | +5.8% | 3,371,263 | -8.1% | 14.17% | +35.5% |
| Q3 2020 | $39,775,000 | -2.7% | 3,669,263 | 0.0% | 10.46% | +16.8% |
| Q2 2020 | $40,876,000 | +52.6% | 3,669,263 | 0.0% | 8.95% | +7.9% |
| Q1 2020 | $26,786,000 | -47.7% | 3,669,263 | 0.0% | 8.29% | -24.8% |
| Q4 2019 | $51,260,000 | – | 3,669,263 | – | 11.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
| VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
| CAXTON CORP | 84,728 | $783,735 | 2.00% |
| COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
| BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
| Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
| TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
| Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
| Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
| Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |